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Amino acid availability activates signaling by the
mammalian target of rapamycin (mTOR) complex 1,
mTORC1, amaster regulator of cell growth. The class
III PI-3-kinaseVps34mediatesaminoacid signaling to
mTORC1 by regulating lysosomal translocation and
activation of the phospholipase PLD1. Here, we
identify leucyl-tRNA synthetase (LRS) as a leucine
sensor for the activation of Vps34-PLD1 upstream
ofmTORC1. LRS is necessary for amino acid-induced
Vps34 activation, cellular PI(3)P level increase,
PLD1 activation, and PLD1 lysosomal translocation.
Leucine binding, but not tRNA charging activity of
LRS, is required for this regulation. Moreover, LRS
physically interacts with Vps34 in amino acid-stimu-
latable non-autophagic complexes. Finally, purified
LRS protein activates Vps34 kinase in vitro in a
leucine-dependent manner. Collectively, our findings
provide compelling evidence for a direct role of LRS
in amino acid activation of Vps34 via a non-canonical
mechanism and fill a gap in the amino acid-sensing
mTORC1 signaling network.
INTRODUCTION
Mammalian target of rapamycin (mTOR) is a Ser/Thr kinase
that controls a wide spectrum of cellular processes including
cell growth, differentiation, and metabolism. mTOR complex 1
(mTORC1), characterized by the presence of raptor, regulates
cell growth by integrating several extracellular and intracellular
signals including mitogens, cellular energy status, oxygen levels,
and amino acid availability (Sarbassov et al., 2005; Wullschleger
et al., 2006). Most signals upstream of mTORC1merge at the tu-
mor suppressor tuberous sclerosis complex TSC1-TSC2 and the
target of its GTPase activity, Rheb (Li et al., 2004; Manning and
Cantley, 2003). Once activated by Rheb, mTORC1 can phos-
phorylate its immediate targets, ribosomal S6 kinase 1 (S6K1)1510 Cell Reports 16, 1510–1517, August 9, 2016 ª 2016 The Author
This is an open access article under the CC BY-NC-ND license (http://and eukaryotic initiation factor 4E binding protein 1 (4EBP1),
both of which regulate protein synthesis at the translational initi-
ation level (Ma and Blenis, 2009).
Phospholipase D (PLD) catalyzes the hydrolysis of phosphati-
dylcholine (PC) to phosphatidic acid (PA), which binds to the
FKBP12-rapamycin-binding domain of mTOR (Fang et al.,
2001). We have reported that PLD1 and PA mediate mTORC1
activation by mitogens (Fang et al., 2001, 2003), and PLD1 is
also a critical mediator of amino acid-induced mTORC1 activa-
tion via vacuolar protein sorting 34 (Vps34) (Yoon et al., 2011).
Vps34 is the only class III PI-3-kinase in mammals, responsible
for producing phosphatidylinositol-3-phosphate (PI(3)P) from
phosphatidylinositol. Vps34 exists in distinct complexes that
contribute to a variety of cellular functions, including vesicular
trafficking and autophagy (Backer, 2008; Russell et al., 2014).
Notably, PI(3)P production by Vps34 is stimulated by amino
acids (Byfield et al., 2005; Nobukuni et al., 2005). Upon amino
acid stimulation, interaction between PI(3)P and the PX domain
of PLD1 activates PLD1 and induces its subcellular transloca-
tion to the lysosome (Yoon et al., 2011), where mTOR is also
recruited via regulation by the small GTPases Rag (Sancak
et al., 2008).
mTORC1 lysosomal translocation and activation in response
to amino acids requires the GTP-bound form of RagA or RagB
as well as the GDP-bound form of RagC or RagD. The Ragulator
complex and the GATOR1 complex act as guanine nucleotide
exchange factor (GEF) and GTPase activating protein (GAP) for
RagA/B, respectively (Bar-Peled et al., 2012, 2013). Sestrins
have been reported to negatively regulate GATOR2, an inhibitor
of GATOR1 and consequently activator of mTORC1 (Chantranu-
pong et al., 2014; Parmigiani et al., 2014; Peng et al., 2014), and a
most recent report from Wolfson et al. (2016) suggests that ses-
trins directly sense leucine in the mTORC1 pathway. A critical
regulator acting in parallel to the sestrin-GATOR pathway has
been reported to be leucyl tRNA synthetase (LRS), which senses
leucine and has GAP activity for RagD (Han et al., 2012).
Although the GAP activity of LRS is under debate (Tsun et al.,
2013), the role of LRS as a leucine sensor upstream of TORC1
has also been independently demonstrated in yeast (Bonfils
et al., 2012).(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. LRS Is Required for Amino Acid Activation of Vps34
(A) HEK293 cells were transduced with lentiviruses expressing shRNAs against LRS (shLRS) or a scrambled sequence as control and selected with puromycin for
3 days. The cells were then transfected with bicistronic Myc-Vps34/V5-Vps15, serum-starved overnight, and leucine (Leu) deprived for 2 hr, followed by leucine
stimulation for 30 min. Cell lysates were analyzed by western blotting. Anti-Myc IP immunocomplexes were subjected to in vitro Vps34 kinase assays.
(B) Cells were treated as in (A) except that amino acid (AA) deprivation and stimulation were performed.
(C) Cells were treated as in (A) except that siRNA against IRS or EPRS were introduced by transfection.
(D) Cells were treated as in (B) and PI(3)P levels were determined by quantitative PI(3)P ELISA assay.
(E) Cells were transduced with shVps34 or control lentiviruses and then co-transfected with Myc-LRS and Myc-S6K1, followed by AA stimulation as in (B).
(F) AA stimulation was performed in the presence of varying concentrations of SAR405.
(legend continued on next page)
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What senses amino acids upstream of Vps34-PLD1 has re-
mained an unanswered question. Here, we report that Vps34 is
a downstream target of LRS in amino acid signaling. LRS directly
interacts with Vps34 in a non-autophagic complex and activates
Vps34 in an amino acid-dependent manner. Vps34 and PLD1
are required to mediate LRS activation of mTORC1. Our findings
reveal LRS as an amino acid sensor for the Vps34-PLD1-
mTORC1 pathway.
RESULTS
LRS Is Required for Amino Acid-Induced Vps34
Signaling
To validate the reported role of LRS in amino acid activation of
mTORC1, we knocked down LRS in HEK293 cells and observed
impaired leucine-stimulated S6K1 phosphorylation (Figure 1A).
Total amino acid stimulation of pS6K1 was also significantly
dampened (Figure 1B). Because there was no known sensor of
amino acids upstream of the Vps34-PLD1-mTORC1 pathway,
we set out to test whether LRS may fulfill that role by examining
the effect of LRS knockdown on Vps34 lipid kinase activity.
Co-expression of Vps15 has been reported to be necessary
to ensure recombinant Vps34 stability and activity (Yan et al.,
2009). Hence, we transfected bicistronic Myc-Vps34/V5-Vps15
into the cells and immunoprecipitated Myc-Vps34 for in vitro ki-
nase assays. Interestingly, knockdown of LRS decreased Vps34
activity induced by leucine (Figure 1A) or total amino acids (Fig-
ure 1B). As an important control, knockdown of two other tRNA
synthetases, isoleucyl-tRNA synthetase (IRS) and glutamyl-
prolyl-tRNA synthetase (EPRS), both in the multi-tRNA synthe-
tase complex together with LRS (Park et al., 2008), had no effect
on leucine-stimulated Vps34 activity (Figure 1C). This is consis-
tent with the previous report that knockdown of these aminoacyl
tRNA synthetases (aaRSs) did not affect mTORC1 activation by
amino acids (Han et al., 2012), suggesting that LRS has a unique
function in mediating mTORC1 activation that is not shared by
other aaRSs. The change in Vps34 activity was paralleled by a
reduction in the total cellular PI(3)P level in LRS knockdown cells
(Figure 1D). Knockdown of LRS did not affect the protein levels of
mTOR, raptor, Vps34, and Rag GTPases (Figure S1A). Hence,
LRS appears to be necessary for amino acid activation of Vps34.
Next, we asked whether Vps34 mediates LRS activation of
mTORC1. Overexpression of LRS enhanced amino acid activa-
tion of S6K1 as previously reported (Han et al., 2012), and this
effect of LRS was abolished by Vps34 knockdown (Figure 1E).
To further validate the link between LRS and Vps34, we utilized
the Vps34-specific inhibitor SAR405, which had been reported
to potently inhibit Vps34 with high selectivity at micromolar con-
centrations (Ronan et al., 2014). Amino acid activation of pS6K1
was inhibited by SAR405 in a dose-dependent manner, with
complete inhibition occurring at 3 mM (Figure 1F). Furthermore,
SAR405 blocked amino acid-stimulated PLD1 activation (Fig-
ure S1B) and translocation to the lysosome (Figure S1C), a pro-(G) Cells were co-transfected with Myc-LRS and Myc-S6K1, stimulated with AA a
SD or representative blots from three to five independent experiments. *p < 0.0
(p% 0.05).
See also Figure S1.
1512 Cell Reports 16, 1510–1517, August 9, 2016cess that requires Vps34 (Yoon et al., 2011). Amino acid-induced
lysosomal translation of mTOR was not affected by the inhibitor
(Figure S1D). Importantly, SAR405 also abolished pS6K1 under
LRS overexpression (Figure 1G), confirming the requirement of
Vps34 for LRS activation of mTORC1 in response to amino
acid signals. Taken together, our results suggest that LRS is an
upstream regulator of amino acid activation of Vps34.
LRS Is Necessary for Amino Acid Activation of PLD1
Because Vps34 activates PLD1 in amino acid signaling (Yoon
et al., 2011), we proceeded to test the effect of LRS on PLD ac-
tivity. LRS knockdown inhibited PLD activity induced by amino
acids (Figure 2A) or leucine alone (Figure 2B), whereas knock-
down of IRS or EPRS had no effect (Figure 2C). Furthermore,
LRS knockdown blocked amino acid-stimulated PLD1 translo-
cation to the lysosome (Figure 2D). Lysosomal translocation of
mTOR was also suppressed by LRS knockdown (Figure 2E),
as previously reported (Han et al., 2012). Collectively, these
results indicate that LRS is required for amino acid regulation
of PLD1.
If mTORC1 were downstream of this LRS-PLD pathway, one
would expect exogenous PA (the product of PLD1) to compen-
sate for signaling to mTORC1 when LRS was knocked down.
This was indeed the case. As shown in Figure 2F (left panels),
PA fully rescued amino acid-stimulated pS6K1 from LRS knock-
down, suggesting that PLD is a major mediator of LRS signaling
to mTORC1. PA partially restored pS6K1 when both LRS and
RagD were knocked down (Figure 2F, right panels), which is
consistent with Rag and PLD acting in parallel to activate
mTORC1 (Yoon et al., 2011).
LRS Is an Amino Acid Sensor in the Vps34-PLD Pathway
To investigate whether leucine binding or catalytic activity of LRS
was involved in the regulation of Vps34-PLD1 signaling, we
made use of two LRS mutants: a leucine binding-deficient
mutant (F50A/Y52A) and a tRNA charging-deficient mutant
(K716A/ K719A) (Han et al., 2012). Overexpression of LRS or
LRS-K716A/K719A, but not LRS-F50A/Y52A, increased amino
acid stimulated S6K1 activity (Figure 3A), as reported previously
(Han et al., 2012). Importantly, LRS, as well as the K716A/K719A
mutant, augmented the total cellular PI(3)P level (i.e., Vps34
activity) and PLD1 activity, whereas the F50A/Y52A mutant did
not have this effect (Figures 3B and 3C). These results indicate
that leucine binding, but not tRNA charging activity of LRS, is
required for activation of the Vps34-PLD1 pathway. This is
consistent with the notion that LRS acts as a sensor for amino
acids independently of its canonical function in translation
regulation.
LRS Physically Interacts with Vps34 and the UNE-L
Domain Is Necessary for LRS Regulation of Vps34
In order to uncover the mechanism underlying LRS regulation of
Vps34, we evaluated a potential physical interaction betweens in (B) in the absence or presence of 3 mMSAR405. All data shown are mean ±
5; **p < 0.01. Data denoted by different letters (a, b) are significantly different
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Figure 2. LRS Is Necessary for Amino Acid Acti-
vation of PLD1
HEK293 cells were transduced with shLRS or control
lentiviruses as described in Figure 1 legend.
(A) Cells were stimulated with AA as described in Figure 1
legend, followed by in vivo PLD assays.
(B) Cells were stimulated with Leu as described in Fig-
ure 1 legend.
(C) Cells were treated as in (A) except that siRNA for IRS
and EPRS were introduced by transfection.
(D) Cells were transduced with shLRS lentivirus and then
transfected with HA-PLD1, followed by AA stimulation
and immunostaining with anti-HA and anti-LAMP1/2
antibodies.
(E) Cells were treated as in (D) without transfection and
immunostained with anti-mTOR and anti-LAMP1/2 anti-
bodies. For (D) and (E), representative images and
quantification of co-localization (overlap coefficient) are
shown.
(F) Cells were transduced with shRNA lentiviruses as
indicated and stimulated with amino acids with or
without 100 mM PA. All data shown are mean ± SD or
representative blots from three to five independent ex-
periments. *p < 0.05; **p < 0.01. Data denoted by
different letters (a, b) are significantly different (p% 0.05).
Scale bars, 5 mm; (enlarged images) 0.5 mm.
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Figure 3. LRS Is an Amino Acid Sensor in
Vps34/PLD1 Signaling
(A) HEK293 cells were transfected with LRS con-
structs as indicated and stimulated with AA as
described in Figure 1 legend, followed by western
analysis.
(B) Cells were treated as in (A) and subjected to
PI(3)P ELISA assays.
(C) Cells were co-transfected with HA-PLD1 and
LRS constructs, treated as in (A), and then sub-
jected to in vivo PLD assays. All data shown are
mean± SDor representative blots from three to five
independent experiments. *p < 0.05; **p < 0.01.LRS and Vps34. We found that endogenous LRS co-immuno-
precipitated with endogenous Vps34 (Figure 4A). Interestingly,
while LRS immunoprecipitates contained Vps34 as well as
EPRS and IRS (Figure 4A, left panels), Vps34 immunoprecipita-
tion brought down only LRS and not the other aaRSs (Figure 4A,
right panels). This suggests that Vps34 interacts with LRS
outside of the multi-tRNA synthetase complex. Recombinant
Myc-Vps34 was also pulled down by Flag-LRS (Figure S2A).
Co-expression of Vps15 did not increase the amount of recom-
binant Vps34 associated with LRS, suggesting that the Vps34-
LRS interaction is not dependent on Vps15 (Figure S2B). As
shown in Figure 4B, the minimum Vps34-binding site resided
within amino acids 361–720 of LRS, although the presence of
the rest of the N terminus appeared to strengthen the interaction.
We also found that the interaction between LRS and Vps34 was
not affected by amino acid withdrawal or stimulation (Figure 4C),
nor by the F50A/Y52A mutation (Figure 4D), suggesting that
leucine binding is not necessary for the LRS-Vps34 interaction.
Despite their capacity to bind Vps34, LRS fragments contain-
ing up to N-terminal 976 amino acids did not activate Vps34,
PLD1, or S6K1 (Figures S3A–S3C). This suggests that Vps34
binding alone is not sufficient for LRS function in the Vps34-
PLD pathway, and the C terminus of LRS may be functionally
important. Indeed, deletion of the C-terminal UNE-L domain
(110 amino acids), present only in higher eukaryotes and spec-
ulated to confer non-translational functions to LRS (Guo et al.,
2010), abolished LRS activation of Vps34 (Figure 4E) and S6K1
(Figure 4F). Hence, the UNE-L domain appears to be required
for the non-canonical function of LRS in activating Vps34-PLD-
mTORC1 signaling.
LRS Interacts with Vps34 in Non-autophagic Complexes
Vps34 is an important autophagy regulator in addition to its role in
amino acid signaling, and it is believed that Vps34 functions
in distinct protein complexes, some regulating autophagy and
others non-autophagic (Backer, 2008; Russell et al., 2014).
Following amino acid starvation, a Vps34 complex containing
Atg14L is involved in autophagy,whereasVps34 complexes lack-
ing Atg14L are not (Yuan et al., 2013). Beclin1 is present in all the
complexes. As shown in Figure S4A (left panels), when endoge-
nous Vps34 was pulled down from mouse embryonic fibroblast
(MEF) cells after preclearing the cell lysate with an anti-Atg14L
antibody, this Vps34 was activated by amino acids. MEF cells1514 Cell Reports 16, 1510–1517, August 9, 2016are commonly used to study Vps34 complexes (Kim et al., 2013;
Russell et al., 2013); we found non-autophagic Vps34 complexes
to be more prevalent in these cells than in HEK293. The activity
of Vps34 associated with Atg14L immunoprecipitates, however,
was inhibited by amino acid stimulation (Figure S4A, right panels),
similar to previous reports (Russell et al., 2013; Yuan et al., 2013).
Hence, only non-autophagic Vps34 complexes are involved in
amino acid signaling tomTOR.Next,weaskedwhichVps34com-
plex binds to LRS. As shown in Figure 4G, when non-autophagic
Vps34 complexes were isolated by immunoprecipitation with
Vps34 or Beclin1, LRS was found in both complexes. The auto-
phagic Vps34 complex isolated by Atg14L immunoprecipitation,
however, did not contain LRS. Therefore, our data suggest that
LRS binds specifically to amino acid-activatable Vps34 in non-
autophagic complexes.
LRS Directly Activates Vps34 Kinase Activity in a
Leucine-Dependent Manner
To further probe a mechanism by which LRS may regulate
Vps34, we performed in vitro kinase assays on Atg14L-depleted
Vps34 complex isolated from amino acid-deprived cells. As
shown in Figure S4B, the addition of leucine to the Vps34 immu-
nocomplex activated the kinase. Endogenous LRS present in the
Vps34 complex most likely contributed to this activation. Impor-
tantly, as shown in Figure 4H, the addition of purified GST-LRS
protein to the immunocomplex enhanced Vps34 kinase activity
by 3-fold when compared to the GST control and this was
dependent on leucine. The leucine-binding-deficient LRSmutant
(F50A/Y52A) also activated Vps34, but to a lesser degree and in a
leucine-independent manner. These results strongly suggest
that LRS directly regulates Vps34 activity. Even though the phys-
ical interaction between these two proteins is not dependent on
amino acid or leucine binding (Figures 4C and 4D), leucine is
critical for LRS regulation of Vps34 activity.
DISCUSSION
Although several regulators mediating amino acid signals in
mTORC1 signaling had been reported, the mechanism by which
amino acids activate Vps34 remained unclear. In the present
study, we have identified LRS as a direct amino acid sensor up-
stream of the Vps34-PLD-mTORC1 pathway. LRS interacts with
and activates Vps34, and this activation is dependent on leucine
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Figure 4. LRS Interacts with and Activates Vps34
(A) LRS or Vps34 was immunoprecipitated from MEF cells, followed by western analysis.
(B) HEK293 cells were transfected with Myc-Vps34 and Flag-LRS wild-type (WT) or fragments as indicated. Anti-Flag IP was performed, followed by western
analysis. A schematic diagram of LRS is shown, in which the point mutations and regions required for Vps34 binding/activation are indicated (based on data
in B and E).
(C) MEF cells were stimulated with AA, followed by IP of Vps34 and western analysis.
(D) HEK293 cells were transfected with Myc-Vps34 and Flag-LRS WT or F50A/Y52A. Anti-Flag IP was performed, followed by western analysis.
(E) HEK293 cells were co-transfected with Myc-Vps34 and WT or mutant LRS and stimulated with AA. Myc-Vps34 was immunoprecipitated and subjected to
in vitro lipid kinase assay.
(F) HEK293 cells were co-transfected with Myc-S6K1 and WT or mutant LRS, followed by AA stimulation and western analysis.
(G) MEF cells were subjected to immunoprecipitation by antibodies against Vps34, Becline1, or Atg14L, followed by western analysis.
(legend continued on next page)
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binding but not tRNA charging activity of LRS. Furthermore, we
show that this regulatory event involves LRS outside of the
multi-tRNA synthetase complex and Vps34 in a non-autophagic
complex. Our structure-function analysis has led to the identifi-
cation of a minimum Vps34-binding site within the N terminus
of LRS and the C-terminal UNE-L domain to be critical for the
activity of LRS toward Vps34.
The multifaceted cellular roles of Vps34, especially in nutrient
signaling, may appear paradoxical. Nutrient starvation has been
shown to both inhibit and activate Vps34 kinase activity (Byfield
et al., 2005; Kim et al., 2013; Nobukuni et al., 2005; Russell et al.,
2013). Characterization of various protein complexes involving
Vps34 has led to insights into its diverse function and regulation.
Amino acid starvation activates Ulk1 following Beclin1 phos-
phorylation, thereby enhancing the activity of Atg14L-containing
Vps34 complex that regulates autophagy, whereas Vps34 in
Atg14L-free complexes is inhibited by amino acid starvation
(Russell et al., 2013). Our observation that LRS associates spe-
cifically with Atg14L-free Vps34 complexes is consistent with
the involvement of LRS in amino acid-activation of Vps34 and
it suggests that LRS differentiates the role of Vps34 in mTORC1
activation from that of regulating autophagy.
It is not clear how LRS regulation of Vps34-PLD can be recon-
ciled with the reported LRS regulation of Rag (Bonfils et al., 2012;
Han et al., 2012). Curiously, the product of PLD, PA, fully rescues
amino acid-stimulated mTORC1 signaling from LRS knockdown
(Figure 2F), suggesting that the Vps34-PLD pathway is a major,
if not the only, mediator of LRS signaling to mTORC1. When
RagD is knocked down in addition to LRS, PA only partially
restores mTORC1 signaling (Figure 2F), consistent with Vps34-
PLD and Rag functioning in parallel to regulate mTORC1 activa-
tion (Yoon et al., 2011). One would also expect the LRS-Vps34-
PLD pathway towork in parallel with the sestrin-GATORpathway
upstream of mTORC1 (Chantranupong et al., 2014; Parmigiani
et al., 2014; Peng et al., 2014; Wolfson et al., 2016).
Because Vps34 must sense amino acids prior to PLD1 trans-
location to the lysosome (Yoon et al., 2011), onewould speculate
that a cytosolic amino acid-sensing event is required for the acti-
vation of the Vps34-PLD1 pathway. In support of this idea, we
observed that neither P62 nor V-ATPase, two previously re-
ported regulators that mediate amino acid-sensing on the lyso-
some (Duran et al., 2011; Zoncu et al., 2011), was involved in
PLD1 translocation to the lysosome, even though V-ATPase inhi-
bition decreased amino acid-induced PLD activity (M.-S.Y. and
J.C., unpublished data). LRS interacts with other aminoacyl
tRNA synthetases and nonenzymatic components to form a
multi-tRNA synthetase complex in the cytosol, which is thought
to be involved in diverse non-canonical functions of the aaRSs
(Park et al., 2008). However, the LRS-Vps34 interaction appears
to occur outside of this complex (Figure 4A). Nevertheless, it
is possible that other factors may be involved in amino acid-
sensing and/or signal transduction by LRS in the cytosol, which
warrants future investigations.(H) MEF cells were serum-starved and amino acid-deprived and then subjected
assayed for lipid kinase activity with or without 0.8 mM leucine. The first lane of th
LRS-F50A/Y52A proteins were included as indicated. *p < 0.05; **p < 0.01. Data
See also Figures S2–S4.
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Detailed information regarding reagents, cell lysis, immunoprecipitation, west-
ern blotting, and immunofluorescence imaging appear in the Supplemental
Experimental Procedures.
Cell Culture and Transfection
HEK293 and MEF cells were grown in DMEM containing 10% fetal bovine
serum (FBS) at 37C with 5% CO2. Transient transfections were per-
formed with PolyFect (QIAGEN) following manufacturers’ recommenda-
tions. Serum or amino acid starvation and various stimulations were
performed as previously described and in figure legends (Sun et al.,
2008). Amino acid stimulation was performed by switching cells from
amino acid-free to regular DMEM. For leucine stimulation, cells were incu-
bated with leucine-free DMEM for 2 hr and stimulated with 0.8 mM leucine
for 30 min.
RNAi
All small hairpin RNAs (shRNAs) were in the pLKO.1-puro lentiviral vector
from The RNAi Consortium (TRC; Sigma-Aldrich). The shRNA clones for hu-
man leucyl tRNA synthetase are shLRS-1 (TRCN0000290440) and shLRS-2
(TRCN0000290511). The shRNA clones for Vps34 and scrambled sequence
control were previously reported (Yoon et al., 2011). Lentivirus packaging
and transduction were performed as previously described (Sun et al., 2008).
The sequences of small interfering (si)EPRS and siIRS were also previously
reported (Han et al., 2006, 2012).
In Vivo PLD Assay
Cellular PLD activity was measured in a transphosphatidylation assay previ-
ously described (Sun et al., 2008). Detailed procedures can be found in the
Supplemental Experimental Procedures.
In Vitro Vps34 Lipid Kinase Assay
GST proteins were expressed in the Escherichia coli strain BL21 and purified
using glutathione Sepharose 4B (GE Healthcare) following the manufacturer’s
protocols. Lipid kinase assayswere performedwith Vps34 immune complexes
with the addition of variousGSTproteins. Detailed procedures are described in
the Supplemental Experimental Procedures.
Determination of Cellular PI(3)P Levels by ELISA
Lipids were extracted from cells and subjected to a competitive ELISA-format
assay (Echelon Biosciences) according to the manufacturer’s manual. PI(3)P
quantities were calculated from non-linear fitting of PI(3)P standards.
Statistical Analysis
All quantitative data are presented as mean ± SD of at least three independent
experiments.Whenever necessary, the statistical significance of the data were
analyzed by performing Student’s t tests (*p% 0.05. **p% 0.01). Data denoted
with different letters (e.g., a, b, c) are significantly different (p% 0.05).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.07.008.
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